1241 ET - Hims & Hers Health's Zava acquisition will expand the company's footprint to major European countries with categories that overlap nicely with its existing offerings, BofA Securities analysts said in a note. However, expanding internationally is a risky move as Hims' core U.S. growth slows. The strategy could reflect product saturation and rising competition domestically. U.S. healthcare technology companies, like Oracle's Cerner and Teladoc's BetterHelp, have had little success in such markets given different regulatory environments in each country. Questions around Hims' future growth prospects remain, the analysts said.(kelly.cloonan@wsj.com)
(END) Dow Jones Newswires
June 03, 2025 12:41 ET (16:41 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。